Singapore Paincare Holdings Gestione

Gestione criteri di controllo 2/4

Singapore Paincare Holdings Il CEO è Bernard Lee, nominato in Dec2018, ha un mandato di 5.92 anni. possiede direttamente 28.48% delle azioni della società, per un valore di SGD 5.94M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.3 anni e 4.5 anni.

Informazioni chiave

Bernard Lee

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	5.9yrs
Proprietà del CEO	28.5%
Durata media del management	5.3yrs
Durata media del Consiglio di amministrazione	4.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Bernard Lee (55 yo)

5.9yrs

Mandato

Dr. Mun Kam Lee, also known as Bernard, is Executive Director and Chief Executive Officer at Singapore Paincare Holdings Limited together with its subsidiaries since 31 December 2018 & serves as it;s Chair...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Mun Kam Lee	CEO & Executive Chairman	5.9yrs	Nessun dato	28.48% SGD 5.9m
Lin Siah Peh	Financial Controller	less than a year	Nessun dato	Nessun dato
Foo Keong Loh	COO & Executive Director	5.3yrs	Nessun dato	16.29% SGD 3.4m
Yoen Har Wong	Company Secretary	no data	Nessun dato	Nessun dato

5.3yrs

Durata media

50yo

Età media

Gestione esperta: Il team dirigenziale di FRQ è esperto e expertise (durata media dell'incarico 5.3 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Mun Kam Lee	CEO & Executive Chairman	5.9yrs	Nessun dato	28.48% SGD 5.9m
Foo Keong Loh	COO & Executive Director	5.3yrs	Nessun dato	16.29% SGD 3.4m
Yee Kong Wong	Independent Non-Executive Director	less than a year	Nessun dato	Nessun dato
Kah Meng Lim	Independent Non-Executive Director	3.7yrs	Nessun dato	Nessun dato

4.5yrs

Durata media

53.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di FRQ sono considerati esperti (durata media dell'incarico 4.5 anni).

Singapore Paincare Holdings Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Singapore Paincare Holdings Limited, Annual General Meeting, Oct 25, 2024

Singapore Paincare Holdings Limited Announces Changes to the Composition of the Board

Singapore Paincare Holdings Limited Appoints Isaac Peh Lin Siah as Financial Controller, Effective August 22, 2024

High number of new directors

Singapore Paincare Holdings Limited Announces the Appointment of Soh Chiong Siong as Financial Controller, Effective April 22, 2024

Insufficient new directors

Recent updates

Full year 2024 earnings released: EPS: S$0.011 (vs S$0.004 loss in FY 2023)

Singapore Paincare Holdings Limited, Annual General Meeting, Oct 25, 2024

Singapore Paincare Holdings Limited Announces Changes to the Composition of the Board

Full year 2024 earnings released: EPS: S$0.012 (vs S$0.003 loss in FY 2023)

Singapore Paincare Holdings Limited Appoints Isaac Peh Lin Siah as Financial Controller, Effective August 22, 2024

New minor risk - Dividend sustainability

Now 23% undervalued

High number of new directors

Singapore Paincare Holdings Limited Announces the Appointment of Soh Chiong Siong as Financial Controller, Effective April 22, 2024

Insufficient new directors

Now 22% undervalued after recent price drop

Singapore Paincare Holdings Limited Announces Yap Beng Tat, Richard Resigns as Independent Non-Executive Director

Singapore Paincare Holdings Limited Announces Resignation of Lim Mong Ai, Karen as Financial Controller

Now 20% undervalued

Singapore Paincare Holdings Limited Proposes Final Dividend (Tax Exempt One-Tier) for the Financial Year Ended 30 June 2023, Payable on November 17, 2023

Full year 2023 earnings released: S$0.003 loss per share (vs S$0.022 profit in FY 2022)

Singapore Paincare Holdings Limited Proposes Final Dividend (Tax Exempt One-Tier) for the Financial Year Ended 30 June 2023

Singapore Paincare Holdings Limited, Annual General Meeting, Oct 27, 2023

Full year 2023 earnings released: S$0.003 loss per share (vs S$0.022 profit in FY 2022)

Singapore Paincare Holdings Limited to Report Fiscal Year 2023 Results on Aug 29, 2023

New minor risk - Financial data availability

Singapore Paincare Holdings Limited Appoints Lim Mong Ai, Karen as Financial Controller, Effective July 1, 2023

First half 2023 earnings released

Singapore Paincare Holdings Limited Appoints Lim Kah Meng as Chairman of the Remuneration Committee and A Member of the Audit Committee and the Nominating Committee

Upcoming dividend of S$0.012 per share

Singapore Paincare Holdings Limited Approves Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 30 June 2022

Full year 2022 earnings released: EPS: S$0.022 (vs S$0.013 in FY 2021)

Singapore Paincare Holdings Limited Announces Cessation of Chong Weng Hoe as Independent Non-Executive Director, Chairman of Remuneration Committee and Member of the Audit Committee and Nominating Committee

Full year 2022 earnings released: EPS: S$0.022 (vs S$0.013 in FY 2021)

Singapore Paincare Holdings Limited Recommends Final Dividend

Singapore Paincare Holdings Limited Announces Promotion of Leow Yong Kin from Financial Controller to Chief Financial Officer

High number of new and inexperienced directors

High number of new and inexperienced directors

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: EPS S$0.013 (vs S$0.031 in FY 2020)

Full year 2021 earnings released: EPS S$0.013 (vs S$0.031 in FY 2020)

Singapore Paincare Holdings Limited Appoints Dr. Lim Kah Meng as Independent Non-Executive Director

First half 2021 earnings released: EPS S$0.004 (vs S$0.01 in 1H 2020)

Singapore Paincare Holdings Limited (Catalist:FRQ) completed the acquisition of 40% stake in KCS Anaesthesia Services Pte. Ltd from Kong Chee Sang.

New 90-day high: S$0.23

Singapore Paincare Holdings Limited (Catalist:FRQ) agreed to acquire 40% stake in Kong Chee Seng fro SGD 2.4 million.

Singapore Paincare Holdings Limited has completed a Follow-on Equity Offering in the amount of SGD 3.96 million.

Full year earnings released - EPS S$0.031

Singapore Paincare Holdings Limited (Catalist:FRQ) entered into agreement to acquire AE Medical Sengkang Private Limited from Wong Shing Yip for SGD 0.17 million.

Singapore Paincare Holdings Limited has completed an IPO in the amount of SGD 5.33412 million.

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media